Dyne Therapeutics Statistics

Total Valuation

DYN has a market cap or net worth of $4.06 billion. The enterprise value is $3.63 billion.

Market Cap	4.06B
Enterprise Value	3.63B

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, before market open.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

DYN has 97.88 million shares outstanding. The number of shares has increased by 43.88% in one year.

Shares Outstanding	97.88M
Shares Change (YoY)	+43.88%
Shares Change (QoQ)	+31.97%
Owned by Insiders (%)	0.40%
Owned by Institutions (%)	98.86%
Float	73.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.49
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.83, with a Debt / Equity ratio of 0.06.

Current Ratio	21.83
Quick Ratio	n/a
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -110.90% and return on invested capital (ROIC) is -52.68%.

Return on Equity (ROE)	-110.90%
Return on Assets (ROA)	-90.00%
Return on Capital (ROIC)	-52.68%
Revenue Per Employee	n/a
Profits Per Employee	-$2.09M
Employee Count	123
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +269.28% in the last 52 weeks. The beta is 1.07, so DYN's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	+269.28%
50-Day Moving Average	33.53
200-Day Moving Average	21.81
Relative Strength Index (RSI)	64.66
Average Volume (20 Days)	1,269,978

Short Selling Information

The latest short interest is 9.08 million, so 9.27% of the outstanding shares have been sold short.

Short Interest	9.08M
Short Previous Month	10.03M
Short % of Shares Out	9.27%
Short % of Float	12.41%
Short Ratio (days to cover)	7.05

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-265.85M
Pretax Income	-257.40M
Net Income	-257.40M
EBITDA	-255.00M
EBIT	-257.40M
Earnings Per Share (EPS)	-$3.97

Full Income Statement

Balance Sheet

The company has $455.47 million in cash and $26.62 million in debt, giving a net cash position of $428.85 million or $4.38 per share.

Cash & Cash Equivalents	455.47M
Total Debt	26.62M
Net Cash	428.85M
Net Cash Per Share	$4.38
Equity (Book Value)	478.06M
Book Value Per Share	4.88
Working Capital	465.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$219.79 million and capital expenditures -$690,000, giving a free cash flow of -$220.48 million.

Operating Cash Flow	-219.79M
Capital Expenditures	-690,000
Free Cash Flow	-220.48M
FCF Per Share	-$2.72

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DYN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.88%
Shareholder Yield	-43.88%
Earnings Yield	-6.34%
FCF Yield	-5.43%

Analyst Forecast

The average price target for DYN is $42.56, which is 2.63% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$42.56
Price Target Difference	2.63%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3